close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TVTX

Recent news which mentions TVTX

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Tickers AIMD AVGR BFLY CALT
Tags SEEL AIMD AVGR
From Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Tickers AFRM AGRI AIMD AMTI
Tags AFRM Benzinga NIR
From Benzinga
Why Shares of Travere Therapeutics Are Slumping Thursday
Tickers MIRM TVTX
Tags TVTX Recent Press Releases Market News
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
Tickers SEEL SEER SGDVV SGHT
Tags VSAT THQ VMO
From Benzinga
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
Tickers CSCO CZOO FDX MURF
Tags Mid Day Market Update NIR Benzinga
From Benzinga
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
Tickers LIFW NEPT NIR QSG
Tags Market News TVTX LIFW
From Benzinga
Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today?
Tickers SNY TVTX
Tags Market News Movers Health Care
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ADXN AMTI AVGR AWH
Tags Benzinga BZI/TFM ORGS
From Benzinga
Broadcom, KB Home And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Tickers AI AVGO CCG KBH
Tags Trading Ideas Markets KBH
From Benzinga
Evercore ISI Group Maintains Outperform Rating for Travere Therapeutics: Here's What You Need To Know
Tickers TVTX
Tags TVTX Market News Benzinga
From Benzinga
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Tickers CALT TVTX XBI
Tags Equities Market News Health Care
From Benzinga
Analyst Ratings for Travere Therapeutics
Tickers TVTX
Tags Analyst Ratings Benzinga Market News
From Benzinga
The Latest Analyst Ratings for Travere Therapeutics
Tickers TVTX
Tags Analyst Ratings Benzinga Market News
From Benzinga
Earnings Scheduled For August 3, 2023
Tickers MYGN MYPS NET NGVC
Tags PLNT VGR SQ
From Benzinga
3 Small-Cap Stocks That Could Be Big-Time Winners
Tickers BLUE TVTX VKTX
Tags TVTX BLUE Recent Press Releases
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Tickers ABT ARWR ATAT ATVI
Tags BZI/Ratings BX ED
From Benzinga
Expert Ratings for Travere Therapeutics
Tickers TVTX
Tags TVTX BZI/AAR Analyst Ratings
From Benzinga
Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation
Tickers MIRM TVTX
Tags Benzinga Biotech TVTX
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tickers ABOS APLS ARGX BBIO
Tags TVTX APLS VRAY
From Benzinga
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say
Tickers KDNY NVS TVTX VERA
Tags TVTX VERA KDNY
From MarketWatch
Analyst Ratings for Travere Therapeutics
Tickers TVTX
Tags TVTX BZI/AAR Analyst Ratings
From Benzinga
3 Biotech Stocks That Could Skyrocket in the Next 12 Months
Tickers BMRN GILD TVTX
Tags TVTX GILD NASDAQ:GILD,NASDAQ:TVTX,NASDAQ:BMRN
From InvestorPlace
3 Biotech Stocks With Blockbuster Potential
Tickers BMRN NVO TVTX
Tags TVTX NYSE:NVO,NASDAQ:BMRN,NASDAQ:TVTX BMRN
From InvestorPlace
11 Analysts Have This to Say About Travere Therapeutics
Tickers TVTX
Tags Benzinga Market News Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Tickers AAPL ANAB AVNS AZUL
Tags AVNS HIBB LUNA
From Benzinga
Recap: Travere Therapeutics Q1 Earnings
Tickers TVTX
Tags BZI/Recaps TVTX Earnings
From Benzinga
Earnings Outlook For Travere Therapeutics
Tickers TVTX
Tags TVTX Earnings BZI/EP
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ANPC AYTU BTCY CADL
Tags IMTX ZJYL SNES
From Benzinga
Chegg, Community Health Systems, Metropolitan Bank And Other Big Stocks Moving Lower On Tuesday
Tickers ANET CACC CHGG CIGI
Tags CIGI CHGG Market News
From Benzinga
Travere Therapeutics' Rare Kidney Disease Drug Disappoints In Phase 3 Study, Analyst Says Efficacy Trends Suggest Potential Path Forward
Tickers TVTX
Tags News General Market News
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today